Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Levy

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 23, 2019
PF-06881893 (Nivestym™), a Filgrastim Biosimilar, Versus US-Licensed Filgrastim Reference Product (US-Neupogen<sup>®</sup>): Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy VolunteersHsuan-Ming Yao, Faith D Ottery, Troy Borema, et al.
Advances in Therapy|June 12, 2020
PF-06881894, a Proposed Biosimilar to Pegfilgrastim, Versus US-Licensed and EU-Approved Pegfilgrastim Reference Products (Neulasta<sup>®</sup>): Pharmacodynamics, Pharmacokinetics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy VolunteersShahrzad Moosavi, Troy Borema, Reginald Ewesuedo, et al.
European Urology Open Science|August 2, 2021
Utilising an Accelerated Delphi Process to Develop Guidance and Protocols for Telepresence Applications in Remote Robotic Surgery TrainingJustin W Collins, Ahmed Ghazi, Danail Stoyanov, et al.
European Urology|January 23, 2019
Utilising the Delphi Process to Develop a Proficiency-based Progression Train-the-trainer Course for Robotic Surgery TrainingJustin W Collins, Jeffrey Levy, Dimitrios Stefanidis, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 23, 2019
PF-06881893 (Nivestym™), a Filgrastim Biosimilar, Versus US-Licensed Filgrastim Reference Product (US-Neupogen<sup>®</sup>): Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy VolunteersHsuan-Ming Yao, Faith D Ottery, Troy Borema, et al.
Advances in Therapy|June 12, 2020
PF-06881894, a Proposed Biosimilar to Pegfilgrastim, Versus US-Licensed and EU-Approved Pegfilgrastim Reference Products (Neulasta<sup>®</sup>): Pharmacodynamics, Pharmacokinetics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy VolunteersShahrzad Moosavi, Troy Borema, Reginald Ewesuedo, et al.
European Urology Open Science|August 2, 2021
Utilising an Accelerated Delphi Process to Develop Guidance and Protocols for Telepresence Applications in Remote Robotic Surgery TrainingJustin W Collins, Ahmed Ghazi, Danail Stoyanov, et al.
European Urology|January 23, 2019
Utilising the Delphi Process to Develop a Proficiency-based Progression Train-the-trainer Course for Robotic Surgery TrainingJustin W Collins, Jeffrey Levy, Dimitrios Stefanidis, et al.
Pageof 2